If you are wondering whether QuidelOrtho at around US$35.38 is starting to look like value or a value trap, you are not alone. That is exactly what this piece will unpack.
The stock has returned 5.6% over the last 7 days and 22.5% over the last 30 days, yet year to date it is at 22.9% with a 1 year return of 15.5% decline and a 3 year return of 59.0% decline, compared with a 5 year return of 83.8% decline.
These moves sit against a backdrop where QuidelOrtho continues to attract attention for its position in healthcare diagnostics, and the market is reacting to shifting expectations about its future role in testing and monitoring solutions. Recent commentary has focused on how investors are reassessing companies that were heavily…
